Table 2 |
||||
|
LCL survival fractions following exposure to 2 Gy IR |
||||
|
Patients |
SLE |
Non-Reactor Controls |
Low ATM Expressers |
A-T |
|
|
||||
|
Average SF2 (%) |
30.40 |
37.50 |
23.1 (10) |
17.2 |
|
36.55 |
38.62 |
25.7 (11) |
9.3 |
|
|
32.08 |
48.83 |
41.6 (13 |
||
|
30.88 |
36.65 |
33.8 (16 |
||
|
32.98 |
45.51 |
|||
|
36.80 |
31.21 |
|||
|
33.42 |
39.11 |
|||
|
29.46 |
35.45 |
|||
|
34.45 |
33.96 |
|||
|
34.83 |
||||
|
35.18 |
||||
|
30.25 |
||||
|
27.18 |
||||
|
38.35 |
||||
|
Mean SF2 |
33.0 ± 3.19 |
39.5 ± 5.98 |
||
|
|
||||
|
Fang et al. Genome Integrity 2010 1:9 doi:10.1186/2041-9414-1-9 |
||||
